We are live on ! Find out more
TELO icon

Telomir Pharmaceuticals
TELO

25 hedge funds and large institutions have $1.74M invested in Telomir Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 2

417% more capital invested

Capital invested by funds: $337K → $1.74M (+$1.4M)

257% more funds holding

Funds holding: 7 → 25 (+18)

0.95% more ownership

Funds ownership: 0.27% → 1.22% (+0.95%)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
25
Holders Change
+18
Holders Change %
+257.14%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$548K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$414K
3
Bank of New York Mellon
Bank of New York Mellon
New York
+$313K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$179K
5
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$146K

Top Sellers

Rank Fund Capital Flow
1
Lido Advisors
Lido Advisors
California
-$77.3K
2
Citigroup
Citigroup
New York
-$69.8K
3
JP Morgan Chase
JP Morgan Chase
New York
-$3.46K
4
FIA
FNY Investment Advisers
New York
-$77
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$423K +$548K +87,899 New
Geode Capital Management
2
Geode Capital Management
Massachusetts
$319K +$414K +66,355 New
Bank of New York Mellon
3
Bank of New York Mellon
New York
$241K +$313K +50,165 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$138K +$179K +28,680 New
SEM
5
Suncoast Equity Management
Florida
$117K – – –
New York State Common Retirement Fund
6
New York State Common Retirement Fund
New York
$113K +$146K +23,400 New
State Street
7
State Street
Massachusetts
$87.2K +$113K +18,127 New
BHWM
8
Beaird Harris Wealth Management
Texas
$70.3K +$62.1K +9,950 +213%
Charles Schwab
9
Charles Schwab
California
$52.2K +$67.7K +10,850 New
Citigroup
10
Citigroup
New York
$31.5K -$69.8K -11,194 -63%
UBS Group
11
UBS Group
Switzerland
$28.5K +$37K +5,931 New
Morgan Stanley
12
Morgan Stanley
New York
$25K +$32.4K +5,199 New
RhumbLine Advisers
13
RhumbLine Advisers
Massachusetts
$24.3K +$31.6K +5,062 New
CF
14
Corebridge Financial
Texas
$12.5K +$16.1K +2,588 New
Bank of America
15
Bank of America
North Carolina
$11.5K +$14.9K +2,390 New
JP Morgan Chase
16
JP Morgan Chase
New York
$9.86K -$3.46K -555 -21%
Wells Fargo
17
Wells Fargo
California
$8.61K +$11.2K +1,790 New
Barclays
18
Barclays
United Kingdom
$7.94K +$10.3K +1,651 New
Osaic Holdings
19
Osaic Holdings
Arizona
$4.81K +$2.5K +400 +67%
TRCT
20
Tower Research Capital (TRC)
New York
$4.56K +$5.92K +948 New
AIP
21
Ameritas Investment Partners
Nebraska
$2.27K +$2.94K +471 New
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$2K +$2.83K +453 New
BNP Paribas Financial Markets
23
BNP Paribas Financial Markets
France
$1.92K +$2.5K +400 New
California State Teachers Retirement System (CalSTRS)
24
California State Teachers Retirement System (CalSTRS)
California
$1.68K +$2.18K +349 New
AB
25
Amalgamated Bank
New York
$1K +$1.04K +166 New
1
2

TELO Hedge Fund Activity: Q2 2024 in Review

25 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Telomir Pharmaceuticals (TELO) for Q2 2024, worth a combined $1.74M — up 417% from $337K a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new TELO positions and 2 closed out — a net gain of 18 holders — while 2 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $548K. The largest seller was Lido Advisors, exiting entirely with an estimated $77.3K sold.

  • 25 institutional investors held Telomir Pharmaceuticals (TELO) as of Q2 2024, up from 7 in Q1 2024.
  • Funds reported $1.74M of Telomir Pharmaceuticals stock for Q2 2024, up 417% quarter-over-quarter.
  • 20 funds opened new Telomir Pharmaceuticals positions in Q2 2024 and 2 closed out, a net change of +18 holders.
  • The largest Telomir Pharmaceuticals buyer in Q2 2024 was BlackRock, an estimated $548K added.
  • The largest Telomir Pharmaceuticals seller in Q2 2024 was Lido Advisors, an estimated $77.3K sold.

Based on aggregated 13F filings for Q2 2024.